Capcom has announced that the HD version of Resident Evil: Revelations on PS4 and Xbox One will be available this fall for a very friendly price of $19.99.

The HD version for the two current-gen consoles features all the content of the original Nintendo 3DS version, which was released back in 2012. All the post-release DLC goodies such as the Rachel Ooze and Lady Hunk Raid Mode costumes and the assortment of weapons in the Enhancement Set and Resistance Set are also included.

Revelations HD on PS4 and Xbox One will support 1080p resolution. The environmental detail and creature movements have also received touch-ups, according to Capcom, which aim to heighten the horror atmosphere. Obviously, the 3D features seen in the original handheld version won't be carried over to this new HD version.

Titled as Biohazard Revelations in Japan, Resident Evil: Revelations is set between Resident Evil 4 and Resident Evil 5. The game centers on familiar characters Jill Valentine and Chris Redfield. Revelations is notable for focusing more on survival, puzzle-solving, and exploration and less on action, which has earned praise from critics and fans alike.

However, players who actually prefer an action-oriented gameplay can still go out with guns blazing in Raid Mode, which remains intact from the original version.

This upcoming HD version marks the second time Revelations has gotten an enhanced version. An HD version for PS3, Xbox 360, Wii U, and PC was also released back in 2013. That one also featured enhanced graphics, though the resolution caps at 720p.

Revelations HD is seen by many as one of the better installments in recent memory, thanks to its return to the classic Resident Evil formula, which has been in and out of the series ever since Resident Evil 4 shifted to an action-oriented gameplay. An episodic sequel, Resident Evil: Revelations 2, was also released in 2015 for PS3, PS4, Xbox One, Xbox 360, and PC. A PS Vita version was also released at a later date. Revelations 2 features Claire Redfield as the main protagonist.